Cover Image
市場調查報告書

印度的靜脈通路裝置·配件市場

India Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite

出版商 iData Research Inc. 商品編碼 601860
出版日期 內容資訊 英文 610 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
印度的靜脈通路裝置·配件市場 India Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite
出版日期: 2017年01月01日 內容資訊: 英文 610 Pages
簡介

本報告提供印度的靜脈通路裝置·配件市場相關調查分析,提供市場概要,趨勢分析,推動市場要素與阻礙要素,競爭分析等系統性資訊。

摘要整理

印度的靜脈通路裝置·配件市場概要

競爭分析

市場趨勢

市場發展

對象市場

主要的調查更新

版本履歷

第1章 調查手法

第2章 疾病概要

  • 基本結構
    • 人的血管系統
  • 血管病變·障礙
    • 癌症
    • 末期腎功能衰竭
    • 糖尿病

第3章 產品的評估

第4章 印度的靜脈通路裝置·配件市場概要

  • 簡介
  • 匯率
  • 市場概要
  • 趨勢分析:各市場區隔
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第5章 置入式埠口市場

  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第6章 Port Needle市場

  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第7章 中央靜脈導管 (CVC) 市場

  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第8章 末梢穿刺中央靜脈導管 (PICC) 市場

  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第9章 週邊靜脈導管 (PIVC) 市場

  • 市場概要
  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

第10章 透析用導管市場

  • 市場分析與預測
  • 促進因素·阻礙因素
  • 競爭市場佔有率分析

簡稱

附錄

目錄
Product Code: iDATA_INVA17_MS

The Indian market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), and dialysis catheters. The Indian market is still undergoing frequent and drastic changes in terms of regulations, shaped by efforts to contain the growing healthcare budget and supporting market growth and development. Recently, the government has been adamant on clearing regulatory hurdles related to imports and exports of medical devices, and has set new standards around clinical trials. In addition, the Indian government runs several health insurance programs designed for high-risk patients to pay upfront cash and then get reimbursed by filing a claim. This process has proven inefficient and slow, and major improvements are possible if better payment mechanisms are implemented.

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

In India, health policy is undergoing extensive reform. The government has been particularly interested in ensuring that basic medical services are available for the whole Indian population and not just for the middle and upper class. According to the World Bank and National Commission's report on Macroeconomics, only 5% of Indians are covered by health insurance policies, which is only available for the urban, middle and high income populations. In addition to healthcare reforms, the government is encouraging private capital investment to improve service quality and meet the public's diverse and complex needs. More reform is required to bring new opportunities to invest in the healthcare market and bring profound change to the healthcare landscape in India. In India, the use of central venous catheters (CVCs) have been experiencing tremendous growth over the past several years due to the rise in the number of seriously ill patients and more complex treatment regimens that require the use of CVCs. Despite the fact that peripherally inserted central catheters (PICCs) are associated with lower infections, and in countries such as Australia the use of PICCs has grown significantly at the expense of CVCs, practitioners in India prefer to use CVCs due to its ease of use and low price.

Table of Contents

LIST OF FIGURES XXIX

LIST OF CHARTS XXXIX

EXECUTIVE SUMMARY 1

INDIA VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 6

MARKET DEVELOPMENTS 7

MARKETS INCLUDED 8

KEY REPORT UPDATES 9

VERSION HISTORY 9

RESEARCH METHODOLOGY 10

  • 1.1 RESEARCH SCOPE 10
  • 1.2 IDATA'S 9-STEP METHODOLOGY 10
    • Step 1: Project Initiation & Team Selection 10
    • Step 2: Prepare Data Systems and Perform Secondary Research 12
    • Step 3: Preparation for Interviews & Questionnaire Design 13
    • Step 4: Performing Primary Research 14
    • Step 5: Research Analysis: Establishing Baseline Estimates 16
    • Step 6: Market Forecast and Analysis 17
    • Step 7: Identify Strategic Opportunities 19
    • Step 8: Final Review and Market Release 20
    • Step 9: Customer Feedback and Market Monitoring 21

DISEASE OVERVIEW 22

  • 2.1 BASIC ANATOMY 22
    • 2.1.1 Human Vascular System 22
  • 2.2 VASCULAR PATHOLOGY AND DISORDERS 23
    • 2.2.1 Cancer 23
    • 2.2.2 End-Stage Renal Disease 24
    • 2.2.3 Diabetes 26

PRODUCT ASSESSMENT 29

INDIA VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 200

  • 4.1 INTRODUCTION 200
  • 4.2 CURRENCY EXCHANGE RATE 201
  • 4.3 MARKET OVERVIEW 202
  • 4.4 TREND ANALYSIS BY SEGMENT 208
  • 4.5 DRIVERS AND LIMITERS 211
    • 4.5.1 Market Drivers 211
    • 4.5.2 Market Limiters 212
  • 4.6 COMPETITIVE MARKET SHARE ANALYSIS 214

IMPLANTABLE PORT MARKET 219

  • 5.1 MARKET OVERVIEW 219
  • 5.2 MARKET ANALYSIS AND FORECAST 223
    • 5.2.1 Total Implantable Port Market 223
    • 5.2.2 Conventional Implantable Port Market 225
    • 5.2.3 Power-Injectable Implantable Port Market 227
  • 5.3 DRIVERS AND LIMITERS 229
    • 5.3.1 Market Drivers 229
    • 5.3.2 Market Limiters 229
  • 5.4 COMPETITIVE MARKET SHARE ANALYSIS 231

PORT NEEDLE MARKET 233

  • 6.1 MARKET OVERVIEW 233
  • 6.2 MARKET ANALYSIS AND FORECAST 236
    • 6.2.1 Total Port Needle Market 236
    • 6.2.2 Conventional Implantable Port Market 238
    • 6.2.3 Safety Port Needle Market 240
  • 6.3 DRIVERS AND LIMITERS 242
    • 6.3.1 Market Drivers 242
    • 6.3.2 Market Limiters 243
  • 6.4 COMPETITIVE MARKET SHARE ANALYSIS 245

CENTRAL VENOUS CATHETER MARKET 247

  • 7.1 MARKET OVERVIEW 247
  • 7.2 MARKET ANALYSIS AND FORECAST 251
    • 7.2.1 Total Central Venous Catheter Market 251
    • 7.2.2 Total Acute Central Venous Catheter Market 253
      • 7.2.2.1 Conventional Acute Central Venous Catheter Market 256
      • 7.2.2.2 Antimicrobial Acute CVC Market 258
    • 7.2.3 Chronic Central Venous Catheter Market 260
  • 7.3 DRIVERS AND LIMITERS 262
    • 7.3.1 Market Drivers 262
    • 7.3.2 Market Limiters 263
  • 7.4 COMPETITIVE MARKET SHARE ANALYSIS 265

PERIPHERALLY INSERTED CENTRAL CATHETER MARKET 268

  • 8.1 MARKET OVERVIEW 268
  • 8.2 MARKET ANALYSIS AND FORECAST 272
    • 8.2.1 Total Peripherally Inserted Central Catheter Market 272
    • 8.2.2 Conventional Peripherally Inserted Central Catheter Market 274
    • 8.2.3 Power-Injectable Peripherally Inserted Central Catheter Market 276
  • 8.3 DRIVERS AND LIMITERS 278
    • 8.3.1 Market Drivers 278
    • 8.3.2 Market Limiters 279
  • 8.4 COMPETITIVE MARKET SHARE ANALYSIS 281

PERIPHERAL INTRAVENOUS CATHETER MARKET 284

  • 9.1 MARKET OVERVIEW 284
  • 9.2 MARKET ANALYSIS AND FORECAST 288
    • 9.2.1 Total Peripheral Intravenous Venous Catheter Market 288
    • 9.2.2 Conventional Peripheral Intravenous Venous Catheter Market 290
    • 9.2.3 Safety Peripheral Intravenous Venous Catheter Market 292
  • 9.3 DRIVERS AND LIMITERS 294
    • 9.3.1 Market Drivers 294
    • 9.3.2 Market Limiters 295
  • 9.4 COMPETITIVE MARKET SHARE ANALYSIS 297

DIALYSIS CATHETER MARKET 300

  • 10.1 MARKET ANALYSIS AND FORECAST 300
  • 10.2 DRIVERS AND LIMITERS 302
    • 10.2.1 Market Drivers 302
    • 10.2.2 Market Limiters 303
  • 10.3 COMPETITIVE MARKET SHARE ANALYSIS 305

ABBREVIATIONS 308

APPENDIX: COMPANY PRESS RELEASES 309

LIST OF CHARTS

  • Chart 1 1: Vascular Access Device and Accessories Market by Segment, India, 2013 - 2023 2
  • Chart 1 2: Vascular Access Device and Accessories Market by Segment, India, 2016 & 2023 3
  • Chart 3 1: Central Venous Catheter Market Segments, 2015 42
  • Chart 4 1: Vascular Access Device and Accessories Market by Segment, India, 2013 - 2023 206
  • Chart 4 2: Vascular Access Device and Accessories Market Breakdown, India, 2016 207
  • Chart 4 3: Vascular Access Device and Accessories Market Breakdown, India, 2023 207
  • Chart 4 4: Growth Rates by Segment, Vascular Access Device and Accessories Market India, 2013 - 2023 210
  • Chart 4 5: Leading Competitors, Vascular Access Device and Accessories Market, India, 2016 218
  • Chart 5 1: Implantable Port Market by Segment, India, 2013 - 2023 221
  • Chart 5 2: Implantable Port Market Breakdown, India, 2016 222
  • Chart 5 3: Implantable Port Market Breakdown, India, 2023 222
  • Chart 5 4: Total Implantable Port Market, India, 2013 - 2023 224
  • Chart 5 5: Conventional Implantable Port Market, India, 2013 - 2023 226
  • Chart 5 6: Power-Injectable Implantable Port Market, India, 2013 - 2023 228
  • Chart 5 7: Leading Competitors, Implantable Port Market, India, 2016 232
  • Chart 6 1: Port Needle Market by Segment, India, 2013 - 2023 234
  • Chart 6 2: Port Needle Market Breakdown, India, 2016 235
  • Chart 6 3: Port Needle Market Breakdown, India, 2023 235
  • Chart 6 4: Total Port Needle Market, India, 2013 - 2023 237
  • Chart 6 5: Conventional Port Needle Market, India, 2013 - 2023 239
  • Chart 6 6: Safety Port Needle Market, India, 2013 - 2023 241
  • Chart 6 7: Leading Competitors, Port Needle Market, India, 2016 246
  • Chart 7 1: Central Venous Catheter Market by Segment, India, 2013 - 2023 249
  • Chart 7 2: Central Venous Catheter Market Breakdown, India, 2016 250
  • Chart 7 3: Central Venous Catheter Market Breakdown, India, 2023 250
  • Chart 7 4: Total Central Venous Catheter Market, India, 2013 - 2023 252
  • Chart 7 5: Total Acute Central Venous Catheter Market, India, 2013 - 2023 255
  • Chart 7 6: Conventional Acute Central Venous Catheter Market, India, 2013 - 2023 257
  • Chart 7 7: Antimicrobial Acute Central Venous Catheter Market, India, 2013 - 2023 259
  • Chart 7 8: Chronic Central Venous Catheter Market, India, 2013 - 2023 261
  • Chart 7 9: Leading Competitors, Central Venous Catheter Market, India, 2016 267
  • Chart 8 1: Peripherally Inserted Central Catheter Market by Segment, India, 2013 - 2023 270
  • Chart 8 2: Peripherally Inserted Central Catheter Market Breakdown, India, 2016 271
  • Chart 8 3: Peripherally Inserted Central Catheter Market Breakdown, India, 2023 271
  • Chart 8 4: Total Peripherally Inserted Central Catheter Market, India, 2013 - 2023 273
  • Chart 8 5: Conventional Peripherally Inserted Central Catheter Market, India, 2013 - 2023 275
  • Chart 8 6: Power-Injectable Peripherally Inserted Central Catheter Market, India, 2013 - 2023 277
  • Chart 8 7: Leading Competitors, Peripherally Inserted Central Catheter Market, India, 2016 283
  • Chart 9 1: Peripheral Intravenous Venous Catheter Market by Segment, India, 2013 - 2023 286
  • Chart 9 2: Peripheral Intravenous Venous Catheter Market Breakdown, India, 2016 287
  • Chart 9 3: Peripheral Intravenous Venous Catheter Market Breakdown, India, 2023 287
  • Chart 9 4: Total Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 289
  • Chart 9 5: Conventional Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 291
  • Chart 9 6: Safety Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 293
  • Chart 9 7: Leading Competitors, Peripheral Intravenous Venous Catheter Market, India, 2016 299
  • Chart 10 1: Total Dialysis Catheter Market, India, 2013 - 2023 301
  • Chart 10 2: Leading Competitors, Dialysis Catheter Market, India, 2016 307

LIST OF FIGURES

  • Figure 1 1: Vascular Access Device and Accessories Market by Segment India, 2016 (1 of 2) 4
  • Figure 1 2: Vascular Access Device and Accessories Market by Segment India, 2016 (2 of 2) 4
  • Figure 1 3: Companies Researched in this Report, India, 2016 5
  • Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, India 6
  • Figure 1 5: Recent Events in the Vascular Access Device and Accessories MarketIndia, 2012 - 2016 7
  • Figure 1 6: Vascular Access Device and Accessories Markets Covered, India, 2016 8
  • Figure 1 7: Key Report Updates 9
  • Figure 1 8: Version History 9
  • Figure 3 1: Class 2 Device Recall Medtronic 99
  • Figure 3 2: Class 2 Device Recall Smiths Medical 99
  • Figure 3 3: Class 2 Device Recall Arrow 100
  • Figure 3 4: Class 2 Device Recall Arrow 100
  • Figure 3 5: Class 2 Device Recall Covidien (Medtronic) 101
  • Figure 3 6: Class 2 Device Recall Arrow 102
  • Figure 3 7: Class 2 Device Recall Medline 102
  • Figure 3 8: Class 2 Device Recall Arrow 102
  • Figure 3 9: Class 2 Device Recall B. Braun 102
  • Figure 3 10: Class 3 Device Recall Bard Access 103
  • Figure 3 11: Class 2 Device Recall Covidien (Medtronic) 103
  • Figure 3 12: Class 2 Device Recall Bard Access 105
  • Figure 3 13: Class 2 Device Recall Bard Access 105
  • Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics 106
  • Figure 3 15: Class 2 Device Recall Bard Access 106
  • Figure 3 16: Class 2 Device Recall Arrow 107
  • Figure 3 17: Class 2 Device Recall Medcomp 107
  • Figure 3 18: Class 2 Device Recall Arrow 107
  • Figure 3 19: Class 2 Device Recall Arrow 108
  • Figure 3 20: Class 2 Device Recall Smiths Medical 108
  • Figure 3 21: Class 2 Device Recall PFM Medical 108
  • Figure 3 22: Class 2 Device Recall PFM Medical 108
  • Figure 3 23: Class 2 Device Recall Becton Dickinson 109
  • Figure 3 24: Class 2 Device Recall Arrow 109
  • Figure 3 25: Class 2 Device Recall Arrow 109
  • Figure 3 26: Class 2 Device Recall Navilyst Medical 109
  • Figure 3 27: Class 2 Device Recall Argon Medical 110
  • Figure 3 28: Class 2 Device Recall Arrow 111
  • Figure 3 29: Class 2 Device Recall Arrow 111
  • Figure 3 30: Class 2 Device Recall Arrow 112
  • Figure 3 31: Class 2 Device Recall Bard Access 112
  • Figure 3 32: Class 2 Device Recall Navilyst Medical 112
  • Figure 3 33: Class 2 Device Recall Bard Access 113
  • Figure 3 34: Class 2 Device Recall Smiths Medical 113
  • Figure 3 35: Class 2 Device Recall B. Braun 113
  • Figure 3 36: Class 2 Device Recall Smiths Medical 114
  • Figure 3 37: Class 2 Device Recall Access Scientific 114
  • Figure 3 38: Class 2 Device Recall Covidien (Medtronic) 114
  • Figure 3 39: Class 2 Device Recall Arrow 115
  • Figure 3 40: Class 2 Device Recall Bard Access 115
  • Figure 3 41: Class 2 Device Recall Becton Dickinson 115
  • Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 116
  • Figure 3 43: Class 2 Device Recall Bard Access 116
  • Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 116
  • Figure 3 45: Class 2 Device Recall Medcomp 117
  • Figure 3 46: Class 2 Device Recall Becton Dickinson 117
  • Figure 3 47: Class 3 Device Recall Bard Access 117
  • Figure 3 48: Class 2 Device Recall Medcomp 118
  • Figure 3 49: Class 1 Device Recall Arrow 118
  • Figure 3 50: Class 2 Device Recall Arrow 118
  • Figure 3 51: Class 2 Device Recall Vygon 118
  • Figure 3 52: Class 2 Device Recall Covidien (Medtronic) 119
  • Figure 3 53: Class 2 Device Recall Medcomp 120
  • Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 120
  • Figure 3 55: Class 2 Device Recall Christie Medical Holdings 120
  • Figure 3 56: Class 3 Recall Bard Access 120
  • Figure 3 57: Class 2 Device Recall AngioDynamics 121
  • Figure 3 58: Class 2 Device Recall Becton Dickinson 121
  • Figure 3 59: Class 2 Device Recall AngioDynamics 121
  • Figure 3 60: Class 2 Device Recall AngioDynamics 123
  • Figure 3 61: Class 3 Device Recall AngioDynamics 124
  • Figure 3 62: Class 2 Device Recall AngioDynamics 124
  • Figure 3 63: Bone Anchored Port - a Novel Vascular Access for Hemodialysis Treatment 126
  • Figure 3 64: A Pragmatic Randomized Trial 126
  • Figure 3 65: Assessment of a Power Injectable vs. a Non-Power Injectable 127
  • Figure 3 66: Vascular Access in Cancer Patients 127
  • Figure 3 67: Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection 127
  • Figure 3 68: Central Line Placement Study 128
  • Figure 3 69: The Effects of Anti-infective Central Venous Catheter (CVC) 128
  • Figure 3 70: The Use of Point of Care Ultra Sound 129
  • Figure 3 71: Complications Associated With Central Venous Access 129
  • Figure 3 72: Impact of Ultrasound Guided Central Venous Catheterization 130
  • Figure 3 73: Randomized, Prospective, Single-center Study 130
  • Figure 3 74: Remifentanil and Local Anesthesia 131
  • Figure 3 75: Dissemination of a Simulation-based Mastery Learning Curriculum 131
  • Figure 3 76: Incidence of Complication 132
  • Figure 3 77: Comparison of Two Needle Insertion Techniques 132
  • Figure 3 78: A Monocenter Prospective Study 133
  • Figure 3 79: A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography 133
  • Figure 3 80: Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation 134
  • Figure 3 81: Use of Chlorhexidine-gel-Impregnated Dressing Compared to Transparent Polyurethane Film Dressing 134
  • Figure 3 82: Vascular Access in Hematological Patients 135
  • Figure 3 83: Developing and Maintaining a Central Venous Catheter Registry 135
  • Figure 3 84: Reliability of Central Venous Pressure Measurements 135
  • Figure 3 85: SUBclavian Central Venous Catheters Guidance and Examination by UltraSound 136
  • Figure 3 86: Chlorhexidine Containing IV-securement Dressings 136
  • Figure 3 87: Comparison of Effectiveness and Safety of Two Methods for Installing Femoral Central Venous Catheters 137
  • Figure 3 88: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters 137
  • Figure 3 89: Ultrasound Guided Diagnosis of Central Venous Catheters in Children 138
  • Figure 3 90: Real-time Ultrasound-guided Catheterization of the Axillary Vein in the Intensive Care Unit 138
  • Figure 3 91: Determination of Anatomic Variations of the Internal Jugular and Femoral Veins 139
  • Figure 3 92: Comparison of Subclavian, Femoral and Internal Jugular Venous Catheterization 139
  • Figure 3 93: Landmark vs. Ultrasound Guided Subclavian Central Venous Catheter Placement 140
  • Figure 3 94: Interest of Ultrasound Coupled to a Guidance System (GPS) 140
  • Figure 3 95: Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement 141
  • Figure 3 96: Comparison of the Central Venous Catheter Insertion Techniques 141
  • Figure 3 97: A Multicenter, Open-label, Randomised, Clinical Trial 142
  • Figure 3 98: A Pragmatic Randomized Trial Standard of Care Vascular Access Strategies 142
  • Figure 3 99: PICC and Midline Related Complications: A Multicenter Observational Study 143
  • Figure 3 100: Complications Associated With Central Venous Access 143
  • Figure 3 101: Evaluation of Electrocardiographic Guidance 143
  • Figure 3 102: Phase II Randomised Study Comparing the Tolerance of PICC Line 144
  • Figure 3 103: Randomized, Prospective, Single-center Study 144
  • Figure 3 104: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion 145
  • Figure 3 105: Ultrasound-guided Peripheral Vascular Access 145
  • Figure 3 106: Vascular Access in Cancer Patients 146
  • Figure 3 107: A Monocenter Prospective Study 147
  • Figure 3 108: Vascular Access in Hematological Patients 147
  • Figure 3 109: ECG Versus Ultrasound-guided Positioning of the Peripherally Inserted Central Catheter (PICC) Tip 147
  • Figure 3 110: Sequential Pneumatic Compression 148
  • Figure 3 111: Reliability of Central Venous Pressure Measurements 148
  • Figure 3 112: Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation 149
  • Figure 3 113: A Randomized Open-labeled Multicenter Study 149
  • Figure 3 114: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters 150
  • Figure 3 115: A Randomized Prospective Multicenter Evaluation 150
  • Figure 3 116: Randomized Double Blind Comparison 151
  • Figure 3 117: An Observational, Prospective, Single-center Study of Placement and Confirmation 151
  • Figure 3 118: PICC and Midline Related Complications 152
  • Figure 3 119: Contribution of Ultrasound for Peripheral Intravenous Catheter Placement by Intensive Care Nurses 152
  • Figure 3 120: A Comparison of Accuvein to Standard Intravenous Access 153
  • Figure 3 121: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access 153
  • Figure 3 122: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture 154
  • Figure 3 123: Ultrasound-guided Peripheral Vascular Access in Children 154
  • Figure 3 124: Preventing Delay of Care in Patient With Difficult IV Access 155
  • Figure 3 125: A Randomized Control Trial of Ultrasound Guided IV Access 155
  • Figure 3 126: Removal Peripheral Intravenous Catheters According to Clinical Signs 156
  • Figure 3 127: Clinical Investigation Acc. To MPG §23b 156
  • Figure 3 128: Evaluation of Accuvein® in Obese Patients 156
  • Figure 3 129: A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device 157
  • Figure 3 130: Technique for Successful Ultrasound-guided Peripheral Vascular Access 157
  • Figure 3 131: A Randomized Controlled Open Label Trial 157
  • Figure 3 132: A Prospective Feasibility Trial of AccuCath® 2.25" BC Intravascular Catheter System 158
  • Figure 3 133: The Use of a Topical Anesthetic Skin Refrigerant 158
  • Figure 3 134: A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein® IV Catheter 159
  • Figure 3 135: Observational Study of the Sonic Window™ Handheld Ultrasound System 159
  • Figure 3 136: Near-Infrared Software Performance Study 159
  • Figure 3 137: A Randomized Controlled Trial To Compare The Initial Success Rate 160
  • Figure 3 138: A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter 160
  • Figure 3 139: Ultrasound Guided Peripheral Intravenous Catheter Insertion 160
  • Figure 3 140: Nurse Peripheral Intravenous Catheter Insertion Success 161
  • Figure 3 141: ACCESS HD Pilot 161
  • Figure 3 142: Randomized Controlled Trial of Straight Versus Coiled Peritoneal Dialysis 162
  • Figure 3 143: Randomized Trial Comparing VectorFlow™ Tunneled Dialysis Catheter 162
  • Figure 3 144: Duration and Adverse Events of Non-cuffed Catheter 162
  • Figure 3 145: Vascular Access Choice and Outcomes in the Elderly and Very Elderly 163
  • Figure 3 146: Prevention of Tunneled Cuffed Catheter Malfunction 163
  • Figure 3 147: Analysis of CRBSI 164
  • Figure 3 148: A Prospective Multicenter Investigation 164
  • Figure 3 149: Comparison of an Intensive Versus a Standard Hemodialysis Central Venous Catheter 164
  • Figure 3 150: Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter for Dialysis 165
  • Figure 3 151: Comparison of Self-locating Catheter Versus a Straight Catheter for Outflow Problems 165
  • Figure 3 152: Multi-Center, Prospective, Randomized, Open-Label, Sponsor-Blinded, Active-Control (Heparin) Clinical Investigation 166
  • Figure 3 153: Comparative Effectiveness of 30% Trisodium Citrate and Heparin Lock Solutions 166
  • Figure 3 154: The Use of Point of Care Ultra Sound for Correct Placement 167
  • Figure 3 155: Contribution of Ultrasound for Peripheral Intravenous Catheter 167
  • Figure 3 156: Evaluation of Electrocardiographic Guidance 168
  • Figure 3 157: Impact of Ultrasound Guided Central Venous Catheterization 168
  • Figure 3 158: A Comparison of Accuvein to Standard Intravenous Access 168
  • Figure 3 159: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access 169
  • Figure 3 160: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture 169
  • Figure 3 161: Incidence of Complication Depending on the Cannulation Site 170
  • Figure 3 162: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion 170
  • Figure 3 163: Ultrasound-guided Peripheral Vascular Access in Children 171
  • Figure 3 164: Preventing Delay of Care in Patient With Difficult IV Access 171
  • Figure 3 165: Ultrasound-guided Peripheral Vascular Access 172
  • Figure 3 166: A Randomized Control Trial of Ultrasound Guided IV Access 172
  • Figure 3 167: Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation 173
  • Figure 3 168: A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography 173
  • Figure 3 169: ECG Versus Ultrasound-guided Positioning 173
  • Figure 3 170: SUBclavian Central Venous Catheters Guidance and Examination 174
  • Figure 3 171: Evaluation of Accuvein® in Obese Patients 174
  • Figure 3 172: Time and Motion Related to PICC Insertion Process 175
  • Figure 3 173: Technique for Successful Ultrasound-guided Peripheral Vascular Access 175
  • Figure 3 174: A Randomized Open-labeled Multicenter Study 176
  • Figure 3 175: Comparison of Effectiveness and Safety of Two Methods for Installing Femoral Central Venous Catheters 176
  • Figure 3 176: Ultrasound Guided Diagnosis of Central Venous Catheters in Children 177
  • Figure 3 177: Real-time Ultrasound-guided Catheterization of the Axillary Vein 177
  • Figure 3 178: Observational Study of the Sonic Window™ Handheld Ultrasound System 178
  • Figure 3 179: Ultrasound-guided Subclavian Vein Puncture 178
  • Figure 3 180: Near-Infrared Software Performance Study 178
  • Figure 3 181: Landmark vs. Ultrasound Guided Subclavian Central Venous Catheter Placement 179
  • Figure 3 182: Interest of Ultrasound Coupled to a Guidance System (GPS) 179
  • Figure 3 183: A Randomized Controlled Trial 180
  • Figure 3 184: A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter 180
  • Figure 3 185: Ultrasound Guided Peripheral Intravenous Catheter Insertion 180
  • Figure 3 186: An Observational, Prospective, Single-center Study 181
  • Figure 3 187: Nurse Peripheral Intravenous Catheter Insertion Success 181
  • Figure 3 188: Unit Based Comparison of Non-Versus Chlorhexidine-Impregnated Central Line Dressings 182
  • Figure 3 189: Use of Chlorhexidine-gel-Impregnated Dressing 182
  • Figure 3 190: Comparing SecurAcath® Versus StatLock® 183
  • Figure 3 191: Chlorhexidine Containing Iv-securement Dressings 183
  • Figure 3 192: A Randomized, Parallel Design Study 184
  • Figure 3 193: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture 184
  • Figure 3 194: Transition From Parenteral Prostanoids to Inhaled Treprostinil 185
  • Figure 3 195: Efficacy, Safety and Acceptability of the New Pen Needle 185
  • Figure 3 196: A Phase I Study of the Safety, Reactogenicity, Acceptability and Immunogenicity 186
  • Figure 3 197: A Single Centre, Randomised, 3-period Cross-over Trial 186
  • Figure 3 198: A Phase IV, Non-Inferiority, Observer Blind, Randomized Clinical Study 187
  • Figure 3 199: Treating Diabetic Lipohypertrophy With Intensive Education 187
  • Figure 3 200: Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin 188
  • Figure 3 201: A Randomized, Multi-centre Cross-over Study 188
  • Figure 3 202: A Clinical Investigation to Evaluate the Safety and Performance 189
  • Figure 3 203: A Phase I, Randomized, Open-Label, Parallel-Group, Single-Dose, Multi-Center Study 189
  • Figure 3 204: Pharmacokinetic and Pharmacodynamic Profile of Insulin Lispro 190
  • Figure 3 205: Reproducibility of Insulin Action When Administered by Needle-free Jet Injection 190
  • Figure 3 206: Patient Experiences With Injection Needles 191
  • Figure 3 207: Inactivated Influenza Via Jet Injection 191
  • Figure 3 208: Intradermal Rabies Immunization Using NanoJect: A Comparative Study 192
  • Figure 3 209: Phase 1b, Partial-Blind, Parallel Group, Randomized Study 192
  • Figure 3 210: A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity 193
  • Figure 4 1: Currency Exchange Rate, 2016 201
  • Figure 4 2: Total Vascular Access Device and Accessories Market, India, 2013 - 2023 (US$M) 203
  • Figure 4 3: Total Vascular Access Device and Accessories Market, India, 2013 - 2023 (IN?M) 203
  • Figure 4 4: Vascular Access Device and Accessories Market by Segment, India, 2013 - 2023 (US$M) 204
  • Figure 4 5: Vascular Access Device and Accessories Market by Segment, India, 2013 - 2023 (IN?M) 205
  • Figure 4 6: Growth Rates by Segment, Vascular Access Device and Accessories Market, India, 2013 - 2023 (1 of 2) 208
  • Figure 4 7: Growth Rates by Segment, Vascular Access Device and Accessories Market, India, 2013 - 2023 (2 of 2) 209
  • Figure 4 8: Drivers and Limiters, Vascular Access Device and Accessories Market, India, 2016 213
  • Figure 4 9: Leading Competitors, Vascular Access Device and Accessories Market, India, 2016 217
  • Figure 5 1: Implantable Port Market by Segment, India, 2013 - 2023 (US$M) 220
  • Figure 5 2: Implantable Port Market by Segment, India, 2013 - 2023 (IN?M) 220
  • Figure 5 3: Total Implantable Port Market, India, 2013 - 2023 223
  • Figure 5 4: Conventional Implantable Port Market, India, 2013 - 2023 225
  • Figure 5 5: Power-Injectable Implantable Port Market, India, 2013 - 2023 227
  • Figure 5 6: Drivers and Limiters, Implantable Port Market, India, 2016 230
  • Figure 5 7: Leading Competitors, Implantable Port Market, India, 2016 232
  • Figure 6 1: Port Needle Market by Segment, India, 2013 - 2023 (US$M) 233
  • Figure 6 2: Port Needle Market by Segment, India, 2013 - 2023 (IN?M) 234
  • Figure 6 3: Total Port Needle Market, India, 2013 - 2023 236
  • Figure 6 4: Conventional Port Needle Market, India, 2013 - 2023 238
  • Figure 6 5: Safety Port Needle Market, India, 2013 - 2023 240
  • Figure 6 6: Drivers and Limiters, Port Needle Market, India, 2016 244
  • Figure 6 7: Leading Competitors, Port Needle Market, India, 2016 246
  • Figure 7 1: Central Venous Catheter Market by Segment, India, 2013 - 2023 (US$M) 248
  • Figure 7 2: Central Venous Catheter Market by Segment, India, 2013 - 2023 (IN?M) 248
  • Figure 7 3: Total Central Venous Catheter Market, India, 2013 - 2023 251
  • Figure 7 4: Total Acute Central Venous Catheter Market, India, 2013 - 2023 253
  • Figure 7 5: Total Acute Central Venous Catheter Market by SegmentIndia, 2013 - 2023 (US$M) 254
  • Figure 7 6: Total Acute Central Venous Catheter Market by SegmentIndia, 2013 - 2023 (IN?M) 254
  • Figure 7 7: Conventional Acute Central Venous Catheter Market, India, 2013 - 2023 256
  • Figure 7 8: Antimicrobial Acute Central Venous Catheter Market, India, 2013 - 2023 258
  • Figure 7 9: Chronic Central Venous Catheter Market, India, 2013 - 2023 260
  • Figure 7 10: Drivers and Limiters, Central Venous Catheter Market, India, 2016 264
  • Figure 7 11: Leading Competitors, Central Venous Catheter Market, India, 2016 266
  • Figure 8 1: Peripherally Inserted Central Catheter Market by Segment, India, 2013 - 2023 (IN?M) 269
  • Figure 8 2: Peripherally Inserted Central Catheter Market by Segment, India, 2013 - 2023 (IN?M) 269
  • Figure 8 3: Total Peripherally Inserted Central Catheter Market, India, 2013 - 2023 272
  • Figure 8 4: Conventional Peripherally Inserted Central Catheter Market, India, 2013 - 2023 274
  • Figure 8 5: Power-Injectable Peripherally Inserted Central Catheter Market, India, 2013 - 2023 276
  • Figure 8 6: Drivers and Limiters, Peripherally Inserted Central Catheter Market, India, 2016 280
  • Figure 8 7: Leading Competitors, Peripherally Inserted Central Catheter Market, India, 2016 282
  • Figure 9 1: Peripheral Intravenous Venous Catheter Market by Segment, India, 2013 - 2023 (US$M) 285
  • Figure 9 2: Peripheral Intravenous Venous Catheter Market by Segment, India, 2013 - 2023 (IN?M) 285
  • Figure 9 3: Total Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 288
  • Figure 9 4: Conventional Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 290
  • Figure 9 5: Safety Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 292
  • Figure 9 6: Drivers and Limiters, Peripheral Intravenous Venous Catheter Market, India, 2016 296
  • Figure 9 7: Leading Competitors, Peripheral Intravenous Venous Catheter Market, India, 2016 298
  • Figure 10 1: Total Dialysis Catheter Market, India, 2013 - 2023 301
  • Figure 10 2: Drivers and Limiters, Dialysis Catheter Market, India, 2016 304
  • Figure 10 3: Leading Competitors, Dialysis Catheter Market, India, 2016 306
  • Figure 12 1: Press Release Summary 309
Back to Top